Finance

Lists
Why is LXEO down ५.२१%?
Dive Deeper
LXEO:NASDAQ
Lexeo Therapeutics Inc
US$ २.९१
-५.२१%
(-०.१६) 1D
नोभेम्बर १२, १२:२९:०८ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LXEO...
Open
US$ ३.०२
High
US$ ३.०५
Low
US$ २.८२
Mkt. cap
२३.८९ करोड
Avg. vol.
१४.५७ लाख
Volume
२.९८ लाख
52-wk high
US$ १०.९९
52-wk low
US$ २.५५
EPS
-US$ १.१६
Shares outstanding
८.२१ करोड
No. of employees
६३
Open
US$ ३.०२
High
US$ ३.०५
Low
US$ २.८२
Mkt. cap
२३.८९ करोड
Avg. vol.
१४.५७ लाख
Volume
२.९८ लाख
52-wk high
US$ १०.९९
52-wk low
US$ २.५५
EPS
-US$ १.१६
Shares outstanding
८.२१ करोड
No. of employees
६३
News stories
From web sources and news partners
marketscreener.com
marketscreener.com
·
२५ मिनेट पहिले
S&P 500, Nasdaq fall as Nvidia CEO's exit rattles AI stocks
TradingView
TradingView
·
५० मिनेट पहिले
Retail put buying reaches contrarian buy zone for S&P 500
The Motley Fool
The Motley Fool
·
३० मिनेट पहिले
Warren Buffett Doesn't Follow His Own S&P 500 Advice. Should You?
About Lexeo Therapeutics Inc
CEO-
Employees६३
Founded२०१७
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 4 analysts giving stock ratings to LXEO in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for LXEO in the last 3 months.
Highest
Current US$ २.९१
US$ २३.०० (+६९०.३८%)
Average
US$ १८.७५ (+५४४.३३%)
Lowest
US$ १५.०० (+४१५.४६%)
Analyst
Recommendation
Action
Price target
Projected
Date
Leland Gershell
Oppenheimer
Buy
Reiterated
US$ २०.००
+५८७.३%
11/11/2026
Kristen Kluska
Cantor Fitzgerald
Buy
Maintained
US$ २३.००
+६९०.४%
11/11/2026
Paul Matteis
Stifel Nicolaus
Buy
Reiterated
US$ १७.००
+४८४.२%
10/05/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$ १५.००
+४१५.५%
09/23/2026
Luca Issi
RBC Capital
Buy
Maintained
US$ २०.००
+५८७.३%
08/12/2026
Tessa Romero
J.P. Morgan
Buy
Maintained
US$ ९.००
+२०९.३%
06/25/2026
Unknown Analyst
Stifel Nicolaus
Buy
Maintained
US$ १७.००
+४८४.२%
05/12/2026
Geulah Livshits
Chardan Capital
Buy
Reiterated
US$ १७.००
+४८४.२%
05/11/2026
Mitchell Kapoor
H.C. Wainwright
Buy
Reiterated
US$ १०.००
+२४३.६%
01/13/2026
Christopher Raymond
Raymond James
Buy
Maintained
US$ २५.००
+७५९.१%
01/13/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
-
-
-
-
Cost of goods sold
१.५७ करोड
१.६२ करोड
१.५७ करोड
१.९० करोड
Cost of revenue
१.५७ करोड
१.६२ करोड
१.५७ करोड
१.९० करोड
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
५९.५३ लाख
६९.०६ लाख
६६.३० लाख
८९.९३ लाख
Operating expense
५९.५३ लाख
६९.०६ लाख
६६.३० लाख
८९.९३ लाख
Total operating expenses
२.१६ करोड
२.३१ करोड
२.२३ करोड
२.८० करोड
Operating income
-२.१६ करोड
-२.३१ करोड
-२.२३ करोड
-२.८० करोड
Other non operating income
-९.०० हजार
९.०० हजार
-१.०० हजार
-६.०० हजार
EBT including unusual items
-२.०३ करोड
-२.०९ करोड
-२.०२ करोड
-२.५९ करोड
EBT excluding unusual items
-२.०२ करोड
-२.०९ करोड
-२.०२ करोड
-२.५८ करोड
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-२.०३ करोड
-२.०९ करोड
-२.०२ करोड
-२.५९ करोड
Net profit margin
-
-
-
-
Earnings per share
-०.३३
-०.२७
-०.२५
-०.३०
Interest and investment income
१४.५६ लाख
२२.१३ लाख
२१.१३ लाख
२१.९४ लाख
Interest expense
-२२.०० हजार
-२०.०० हजार
-१७.०० हजार
-१४.०० हजार
Net interest expenses
१४.३४ लाख
२१.९३ लाख
२०.९६ लाख
२१.८० लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
-२.१५ करोड
-२.३० करोड
-२.२२ करोड
-२.७९ करोड
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू